Maryland
Phase 2 colorectal cancer trials in Maryland
11 Phase 2 colorectal cancer studies are recruiting participants at sites in 3 cities across Maryland as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Recently updated studies in Maryland
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Phase 2
- Ages 18 to 72
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT01174121 · updated
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Solstice Oncology, Inc.
- Recruiting in
- Baltimore
- Registry record
- NCT07808151 · updated
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Dustin Deming
- Recruiting in
- Baltimore
- Registry record
- NCT06493019 · updated
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Christian Hinrichs
- Recruiting in
- Bethesda
- Registry record
- NCT05686226 · updated
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Phase 2
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT05286814 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Baltimore
- Registry record
- NCT07023289 · updated
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- NSABP Foundation Inc
- Recruiting in
- Baltimore
- Registry record
- NCT07058012 · updated
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Recruiting in
- Baltimore
- Registry record
- NCT07281768 · updated
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SCRI Development Innovations, LLC
- Recruiting in
- Columbia
- Registry record
- NCT07011576 · updated
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Recruiting in
- Baltimore
- Registry record
- NCT06205836 · updated
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- NGM Biopharmaceuticals, Inc
- Recruiting in
- Baltimore
- Registry record
- NCT07033026 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Maryland on ClinicalTrials.gov.
Ask about studies in Maryland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections